Poor training - Cytogenetic Technician bei NeoGenomics: Mitarbeiterbewertung

3.0
1. Apr. 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Good pay for the market

Kontras

Poor management and training, and management doesn’t seem to have planning. Safety concerns not taken seriously. Department has incredibly poor PTO system, don’t expect any for 8 months after hire.

Mehr Bewertungen zu NeoGenomics entdecken

5.0
11. März 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Growing business opportunities for many job seekers

Kontras

Ever changing approach on direction on projects

2.0
2. März 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

The workforce wants to do the right thing. We take pride in knowing our services impact people's lives everyday.

Kontras

Constant turnover, lack of communication throughout - top to bottom. Leadership is struggling and not performing, Most of their attempts to improve growth have lost money. This is factual, not to be mistaken with statements from a disgruntled employee. An article published after the recent earnings release emphasized NEO's 5-year Return on Invested Capital is -10.5%, meaning management doesn't spend our capital wisely. This, along with heavy debt, minimal cash and returns at the bottom of the healthcare sector, should make you pause and do more research before jumping on board.

5
Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle